SEC 13F Intelligence

Man Group PLC / ELV

Man Group PLC’s Elevance Health Inc Formerly Position

Does Man Group PLC own Elevance Health Inc Formerly (ELV)? Yes41.6K shares worth $12M (+0.02% of its 13F portfolio) as of Q1 2026, up from 35.9K shares the prior filed quarter.

Position Value
$12M
Q1 2026
Shares
41.6K
% of Portfolio
+0.02%
Quarters Held
30
currently held

Position History ELV

Reported value by quarter
Q4 ’18: $19MQ4 ’18Q1 ’19: $57MQ2 ’19: $59MQ3 ’19: $90MQ4 ’19: $88MQ4 ’19Q1 ’20: $10MQ2 ’20: $59MQ3 ’20: $82MQ4 ’20: $74MQ4 ’20Q1 ’21: $99MQ2 ’21: $53MQ3 ’21: $68MQ4 ’21: $122MQ4 ’21Q1 ’22: $79MQ2 ’22: $98MQ3 ’22: $101MQ4 ’22: $151MQ4 ’22Q1 ’23: $174MQ2 ’23: $228MQ3 ’23: $288MQ4 ’23: $298MQ4 ’23Q1 ’24: $188MQ2 ’24: $145MQ3 ’24: $97MQ4 ’24: $23MQ4 ’24Q1 ’25: $38MQ2 ’25: $65MQ3 ’25: $12MQ4 ’25: $13MQ4 ’25Q1 ’26: $12Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 202641.6K$12M+0.02%
Q4 202535.9K$13M+0.02%
Q3 202536.2K$12M+0.02%
Q2 2025166.5K$65M+0.12%
Q1 202588.0K$38M+0.10%
Q4 202463.5K$23M+0.06%
Q3 2024186.4K$97M+0.25%
Q2 2024268.3K$145M+0.37%
Q1 2024363.2K$188M+0.47%
Q4 2023631.9K$298M+0.83%
Q3 2023662.5K$288M+0.89%
Q2 2023514.0K$228M+0.70%
Q1 2023378.3K$174M+0.62%
Q4 2022294.7K$151M+0.54%
Q3 2022221.9K$101M+0.47%
Q2 2022202.8K$98M+0.41%
Q1 2022160.4K$79M+0.27%
Q4 2021263.3K$122M+0.39%
Q3 2021183.1K$68M+0.24%
Q2 2021138.1K$53M+0.19%
Q1 2021276.1K$99M+0.44%
Q4 2020229.0K$74M+0.32%
Q3 2020303.8K$82M+0.32%
Q2 2020222.8K$59M+0.30%
Q1 202045.3K$10M+0.07%
Q4 2019291.6K$88M+0.29%
Q3 2019373.9K$90M+0.33%
Q2 2019208.7K$59M+0.21%
Q1 2019200.1K$57M+0.22%
Q4 201871.4K$19M+0.08%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Man Group PLC’s full portfolio or all institutional holders of ELV.